GSNKGAIIGLM
CAS No. ——
GSNKGAIIGLM( Amyloid beta-peptide(25-35) )
Catalog No. M21170 CAS No. ——
GSNKGAIIGLM is the fragment Aβ(25-35) of the Alzheimer's amyloid β-peptide.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 239 | Get Quote |
|
| 10MG | 381 | Get Quote |
|
| 25MG | 687 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGSNKGAIIGLM
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSNKGAIIGLM is the fragment Aβ(25-35) of the Alzheimer's amyloid β-peptide.
-
DescriptionGSNKGAIIGLM is the fragment Aβ(25-35) of the Alzheimer's amyloid β-peptide.
-
In Vitro——
-
In Vivo——
-
SynonymsAmyloid beta-peptide(25-35)
-
PathwayMembrane Transporter/Ion Channel
-
TargetBeta Amyloid
-
Recptoramyloid-β
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight1288.32
-
Molecular FormulaC49H83F6N13O18S
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (94.32 mM; Need ultrasonic)H2O:3.33 mg/mL (3.14 mM; Need ultrasonic)
-
SMILESFC(F)(F)C(=O)O.FC(F)(F)C(=O)O.O=C(N[C@@H](CCSC)C(=O)O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Buntanetap
Buntanetap ((+)-Phenserine) is an orally active inhibitor of polyneurotoxic proteins (TINAPs) for the study of neurological disorders, endocrine and metabolic disorders, and cardiovascular diseases.
-
β-Amyloid 31-35
β-Amyloid (31-35) is the shortest sequence of native Amyloid-β peptide that retains neurotoxic activity. This synthetic peptide consists of amino acids 31 to 35 of beta amyloid protein.
-
RAGE antagonist pept...
Receptor for advanced glycation end products (RAGE) antagonist. Blocks S100P, S100A4 and HMGB-1 mediated RAGE activation in vitro and in vivo. Inhibits growth and metastasis of rat glioma tumors. Reduces cell growth and RAGE-mediated NF-κB activity in human PDAC cell lines. Inhibits effects of TDI exposure in BALB/c mice.
Cart
sales@molnova.com